Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$3.16B |
| 2 |
Merck
MRK
|
+$2.72B |
| 3 |
SLB Ltd
SLB
|
+$1.62B |
| 4 |
Target
TGT
|
+$1.6B |
| 5 |
General Mills
GIS
|
+$930M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.81B |
| 2 |
Blackrock
BLK
|
+$2.57B |
| 3 |
US Bancorp
USB
|
+$1.84B |
| 4 |
M&T Bank
MTB
|
+$808M |
| 5 |
Huntington Bancshares
HBAN
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.45% |
| 2 | Financials | 11.9% |
| 3 | Healthcare | 10.6% |
| 4 | Consumer Discretionary | 9.01% |
| 5 | Industrials | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
URG
3026
Ur-Energy
URG
$517M
| $575K | ﹤0.01% |
853,212
| – | – |
|
3027
Utah Medical Products
UTMD
$227M
| $575K | ﹤0.01% |
10,252
-179
| -2% | -$10.7K |
|
|
PINE
3028
Alpine Income Property Trust
PINE
$330M
| $574K | ﹤0.01% |
34,359
-1,798
| -5% | -$29.7K |
|
3029
John Marshall Bancorp
JMSB
$335M
| $572K | ﹤0.01% |
34,647
+1
| +0% | +$19 |
|
|
GRDN
3030
Guardian Pharmacy Services
GRDN
$2.56B
| $572K | ﹤0.01% |
26,908
+56
| +0.2% | +$1.15K |
|
|
EEX
3031
DELISTED
Emerald Holding
EEX
| $572K | ﹤0.01% |
145,533
-3,765
| -3% | -$16.2K |
|
|
TTSH
3032
DELISTED
Tile Shop Holdings
TTSH
| $571K | ﹤0.01% |
88,087
+336
| +0.4% | +$2.36K |
|
3033
Fidelity D&D Bancorp
FDBC
$313M
| $570K | ﹤0.01% |
13,705
+684
| +5% | +$30.2K |
|
|
TERN
3034
DELISTED
Terns Pharmaceuticals
TERN
| $570K | ﹤0.01% |
206,450
| – | – |
|
3035
PCB Bancorp
PCB
$397M
| $566K | ﹤0.01% |
30,252
+1,000
| +3% | +$19.3K |
|
3036
Compass Therapeutics
CMPX
$340M
| $566K | ﹤0.01% |
297,880
+11,689
| +4% | +$31.1K |
|
3037
Bankwell Financial Group
BWFG
$536M
| $562K | ﹤0.01% |
18,636
+1,000
| +6% | +$30.4K |
|
3038
Magnachip Semiconductor
MX
$134M
| $560K | ﹤0.01% |
163,340
-2,212
| -1% | -$9.31K |
|
3039
Norwood Financial Corp
NWFL
$371M
| $560K | ﹤0.01% |
23,165
+2,628
| +13% | +$67.4K |
|
|
FRGE
3040
DELISTED
Forge Global Holdings
FRGE
| $560K | ﹤0.01% |
66,399
+7,703
| +13% | +$89K |
|
3041
Lifecore Biomedical
LFCR
$167M
| $560K | ﹤0.01% |
79,495
+5,068
| +7% | +$31.5K |
|
3042
MVB Financial
MVBF
$395M
| $557K | ﹤0.01% |
32,148
| – | – |
|
3043
Fate Therapeutics
FATE
$303M
| $556K | ﹤0.01% |
703,825
-66,455
| -9% | -$81.4K |
|
|
BRT
3044
BRT Apartments
BRT
$267M
| $554K | ﹤0.01% |
32,562
-15
| -0% | -$265 |
|
3045
Weyco Group
WEYS
$418M
| $550K | ﹤0.01% |
18,059
+903
| +5% | +$30.7K |
|
3046
Torrid Holdings
CURV
$258M
| $548K | ﹤0.01% |
100,017
-1,705
| -2% | -$10.2K |
|
3047
Inspired Entertainment
INSE
$185M
| $544K | ﹤0.01% |
63,746
+50
| +0.1% | +$481 |
|
3048
Redwire
RDW
$2.56B
| $544K | ﹤0.01% |
65,645
+4
| +0% | +$66 |
|
3049
Arteris
AIP
$1.43B
| $544K | ﹤0.01% |
78,690
| – | – |
|
3050
Orion Group Holdings
ORN
$418M
| $543K | ﹤0.01% |
103,845
| – | – |
|
Similar funds
Charles Schwab's Q1 2025 Portfolio in Review
As of Q1 2025, Charles Schwab held 3,548 positions worth $533B, down 1.7% from $542B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.6%. Charles Schwab opened 55 new positions and exited 74, leaving the 3,548-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2025 buy was iShares Currency Hedged MSCI Eurozone ETF: 7,259,426 shares worth $283M.
- Charles Schwab added most to ConocoPhillips in Q1 2025, an estimated $3.16B increase.
- Charles Schwab's biggest Q1 2025 reduction was Pfizer, cutting an estimated $2.81B.
- Charles Schwab fully exited Brookfield in Q1 2025, selling an estimated $218M.
- Charles Schwab's ten largest holdings make up 20% of its $533B portfolio in Q1 2025.
- Charles Schwab opened 55 new positions and closed 74 in Q1 2025.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $533B.
Based on Charles Schwab's 13F filing for Q1 2025, filed 9 May 2025.